-

Innovaccer Recognized in Frost & Sullivan Report for Advancing AI in Healthcare Delivery

Report highlights Innovaccer's transformative impact on healthcare through AI, detailing strategies for enhancing clinical efficiency, improving documentation accuracy, and elevating data accessibility.

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, announced that it was featured in Frost & Sullivan’s latest report, "Shaping the Future of Healthcare Delivery Through Provider Copilot AI Technologies." The report examines the evolving landscape of healthcare AI, with Innovaccer spotlighted as a leading innovator for its holistic approach to generative AI scribing solutions and its established track record in solving key provider pain points through cloud-based technologies.

"We're not just riding the AI hype train; we're weaving AI into the fabric of healthcare to provide holistic, contextual insights that empower clinicians and enhance patient outcomes," said Abhinav Shashank, cofounder and CEO of Innovaccer. "Our Provider Copilot tackles real challenges healthcare providers face every day. By automating routine tasks and offering clinical insights, we're freeing up more time for patient care. We're humbled and honored by this recognition from Frost and Sullivan, affirming our commitment to developing solutions that not only improve healthcare delivery but also make it fundamentally easier for all stakeholders involved."

The report underscores Innovaccer's role in driving the future of healthcare with AI-driven solutions that significantly enhance clinical workflows, improve documentation accuracy, and elevate patient care. Innovaccer's Provider Copilot, developed specifically for healthcare providers, is also recognized for its innovative ambient documentation, clinical insights, and seamless EMR integration capabilities.

"Our studies show that Innovaccer's Provider Copilot can reduce documentation time by up to 40%, which directly translates to improved patient throughput and satisfaction," noted Frost & Sullivan healthcare analysts. "This substantial reduction in time spent on administrative tasks enables healthcare providers to allocate more time to patient care, enhancing overall healthcare delivery."

Daniel Ruppar, Consulting Director at Frost & Sullivan, highlighted the impact of Innovaccer's technologies, stating, "Innovaccer's AI solutions are not just enhancements but are pivotal transformations in healthcare operations and strategic planning. Their technology facilitates improved interactions between providers and patients and significantly better care outcomes."

The report also emphasizes Innovaccer's adherence to responsible AI practices, including maintaining human oversight and not using customer data for training other AI models, showcasing their dedication to security and ethical standards.

For a comprehensive understanding of Frost & Sullivan's insights into Innovaccer and to explore the impact of the Innovaccer Provider Copilot on healthcare efficiency and effectiveness, please visit Innovaccer's website.

About Innovaccer

Innovaccer is the data platform that accelerates care innovation through innovative AI technologies. Innovaccer’s AI-powered healthcare platform unifies patient data across systems and care settings, empowering healthcare organizations with scalable, modern applications that improve clinical, financial, operational, and experiential outcomes. Innovaccer’s EHR-agnostic solutions have been deployed across more than 1,600 hospitals and clinics in the US, enabling care delivery transformation for over 96,000 clinicians. Innovaccer has helped its customers unify health records for over 54 million people and generate more than $1.5 billion in cumulative cost savings. Recognized as an industry-leading data and analytics platform, the Best in KLAS CRM solution, and the #1 rated population health technology platform by Black Book, Innovaccer is committed to driving healthcare excellence. For more information, visit innovaccer.com.

About Frost & Sullivan

Frost & Sullivan, a global research and consulting firm, assists corporations in achieving sustained growth through the development and implementation of significant growth strategies. Their unique Growth Pipeline as a Service model ensures continuous development and evaluation of robust growth strategies.

Contacts

Arushi Awasthi
Innovaccer Inc.
arushi.awasthi@innovaccer.com
415-462-2139

​Innovaccer Inc.


Release Versions

Contacts

Arushi Awasthi
Innovaccer Inc.
arushi.awasthi@innovaccer.com
415-462-2139

More News From ​Innovaccer Inc.

Innovaccer and Hospitalogy Release ‘Autonomous Healthcare’ Report, Revealing Key Margin and Operating Trends Across Major Health Systems

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, and Hospitalogy, a healthcare research and intelligence firm, today announced the release of a new joint report, Autonomous Healthcare is Here: The 2026 Health System Paradigm Shift. The 60-page report provides an in-depth analysis of 2025 health system financial performance, operating strategies, and AI opportunities shaping the next era of US health systems. The research analyzes 15 of the country’s largest not-...

Community Care of North Carolina Partners with Innovaccer to Advance Value-Based Care Delivery for Independent Primary Care Providers in North Carolina

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, today announced a five-year partnership with Community Care of North Carolina, Inc. (CCNC), the state’s largest and longest-running medical home system currently serving more than one million members. The partnership will leverage Innovaccer’s Healthcare Intelligence Cloud to enable CCNC care managers to identify and assist the appropriate patients at the optimal time and provide CCPN clinicians with powerful data...

Pharmacy Quality Solutions Announces Strategic Partnership with Pyrls to Transform Clinical Workflow for Pharmacists

SAN FRANCISCO--(BUSINESS WIRE)--Pharmacy Quality Solutions (PQS), an Innovaccer company and leader in pharmacy-payer performance technology, today announced a strategic partnership with Pyrls, the Y Combinator-backed clinical drug information platform trusted by over 50,000 clinicians and student clinicians. This collaboration integrates Pyrls' powerful drug information hub directly into EQUIPP Copilot, creating a seamless experience that supercharges clinical insights and empowers clinicians t...
Back to Newsroom